MedKoo Cat#: 412352 | Name: Carfenazine free base
Featured

Description:

WARNING: This product is for research use only, not for human or veterinary use.

Carfenazine, also known as WY-2445, or carphenazine (BAN), also known as carphenazine maleate (USAN) (brand name Proketazine; former developmental code name NSC-71755), is an antipsychotic and tranquilizer of the phenothiazine group that was withdrawn from the market. Carphenazine blocks postsynaptic mesolimbic dopaminergic D1 and D2 receptors in the brain; depresses the release of hypothalamic and hypophyseal hormones and is believed to depress the reticular activating system thus affecting basal metabolism, body temperature, wakefulness, vasomotor tone, and emesis.

Chemical Structure

Carfenazine free base
Carfenazine free base
CAS#2622-30-2 (free base)

Theoretical Analysis

MedKoo Cat#: 412352

Name: Carfenazine free base

CAS#: 2622-30-2 (free base)

Chemical Formula: C24H31N3O2S

Exact Mass: 425.2137

Molecular Weight: 425.59

Elemental Analysis: C, 67.73; H, 7.34; N, 9.87; O, 7.52; S, 7.53

Price and Availability

Size Price Availability Quantity
5mg USD 550.00 2 Weeks
10mg USD 950.00 2 Weeks
Bulk Inquiry
Buy Now
Add to Cart
Synonym
NSC-71755; NSC71755; NSC 71755, Carphenazine free base; Proketazine; Proketazine; Procethazine; carphenazine; WY2445; WY-2445; WY 2445;
IUPAC/Chemical Name
1-(10-(3-(4-(2-hydroxyethyl)piperazin-1-yl)propyl)-10H-phenothiazin-2-yl)propan-1-one
InChi Key
XZSMZRXAEFNJCU-UHFFFAOYSA-N
InChi Code
InChI=1S/C24H31N3O2S/c1-2-22(29)19-8-9-24-21(18-19)27(20-6-3-4-7-23(20)30-24)11-5-10-25-12-14-26(15-13-25)16-17-28/h3-4,6-9,18,28H,2,5,10-17H2,1H3
SMILES Code
CCC(C(C=C1N2CCCN3CCN(CCO)CC3)=CC=C1SC4=C2C=CC=C4)=O
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>3 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
More Info

Preparing Stock Solutions

The following data is based on the product molecular weight 425.59 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
1: STRATAS NE. CARPHENAZINE IN CHRONIC SCHIZOPHRENICS. Am J Psychiatry. 1964 Mar;120:902-3. doi: 10.1176/ajp.120.9.902. PMID: 14129292. 2: LASALLE MW. CARPHENAZINE IN CHRONIC SCHIZOPHRENIA. Am J Psychiatry. 1964 Nov;121:494-5. doi: 10.1176/ajp.121.5.494. PMID: 14218188. 3: RUSSELL PB. Chemistry of carphenazine. Dis Nerv Syst. 1961 Feb;22(2)Suppl:5-6. PMID: 13744855. 4: CORNEILLE HJ. ALLERGIC PURPURA IN A PATIENT TREATED WITH CARPHENAZINE. Am J Psychiatry. 1965 Feb;121:814-5. doi: 10.1176/ajp.121.8.814. PMID: 14267601. 5: OLTMAN JE, FRIEDMAN S. Carphenazine in the treatment of schizophrenia. Dis Nerv Syst. 1961 Feb;22(2)Suppl:37-41. PMID: 13730922. 6: TISLOW R. Pharmacology and toxicity of carphenazine. Dis Nerv Syst. 1961 Feb;22(2)Suppl:7-13. PMID: 13777037. 7: KOTHARI NJ, PARK IH, KLINE NS, SAUNDERS JC. Carphenazine therapy in hospitalized patients. Dis Nerv Syst. 1961 Feb;22(2)Suppl:58-9. PMID: 13753477. 8: CHEN CH, POIM S. Carphenazine in the treatment of schizophrenia. Curr Ther Res Clin Exp. 1963 Apr;5:195-7. PMID: 14020488. 9: CARTER CH. Carphenazine in mental defectives: a specific antiemetic. Arch Pediatr (N Y). 1961 Sep;78:349-56. PMID: 13691129. 10: HOSKO MJ Jr. EEG effects of carphenazine. Dis Nerv Syst. 1961 Feb;22(2)Suppl:14-8. PMID: 13716073. 11: Hanenson I. Carphenazine in the intensive care of chronically ill psychotics. Int J Neuropsychiatry. 1967 Aug;3(4):332-6. PMID: 4863506. 12: BRONSKY I. CARPHENAZINE THERAPY OF ACUTELY PSYCHOTIC PATIENTS IN THE PSYCHIATRIC WARD OF A GENERAL HOSPITAL. Am J Psychiatry. 1965 Jun;121:1203-4. doi: 10.1176/ajp.121.12.1203. PMID: 14286057. 13: Orzack MH, Kornetsky C, Freeman H. The effects of daily administration of carphenazine on attention in the schizophrenic patient. Psychopharmacologia. 1967;11(1):31-8. doi: 10.1007/BF00401506. PMID: 4876301. 14: WELSH AL. THE NEWER TRANQUILIZING DRUGS. Med Clin North Am. 1964 Mar;48:459-81. doi: 10.1016/s0025-7125(16)33476-9. PMID: 14149245. 15: Vinar O, Formánková M, Taussigová D, Růzicka S. Carphenazine in the treatment of schizophrenic psychoses. Controlled clinical trial. Act Nerv Super (Praha). 1967 Nov;9(4):353-5. PMID: 4889058. 16: BARSA JA, SAUNDERS JC. Carphenazine in the treatment of chronic schizophrenics. Am J Psychiatry. 1962 Aug;119:169. doi: 10.1176/ajp.119.2.169. PMID: 13865331. 17: TIANGCO E. Intensive hepatological studies using carphenazine. Am J Psychiatry. 1962 Mar;118:845-6. doi: 10.1176/ajp.118.9.845. PMID: 13921145. 18: FOX V. Carphenazine in the withdrawal phase of acute alcoholism. J Med Assoc Ga. 1963 Apr;52:167-70. PMID: 13959058. 19: NIVER EO. Carphenazine and the extrapyramidal regulation of kinesthetic function. Dis Nerv Syst. 1962 Jun;23:340-8. PMID: 14480089. 20: SIMS W. QUALITATIVE AND QUANTITATIVE TESTS FOR CARPHENAZINE MALEATE. J Pharm Sci. 1964 Jan;53:101-3. doi: 10.1002/jps.2600530121. PMID: 14106361.